The DOI matches its Crossref record; 327 of the 327 references it cites were found in a registry or an index.
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–327 of 327
Stafylidou, M., Paschos, P., Katsoula, A., Malandris, K., Ioakim, K., Bekiari, E., Haidich, A., Akriviadis, E. A., & Τσάπας, Α. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.04.062 · Cited by 133
Racial differences in nonalcoholic fatty liver disease in the U.S. population
Schneider, A. L. C., Lazo, M., Selvin, E., & Clark, J. M. (2013) · Obesity · doi:10.1002/oby.20426 · Cited by 130
Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis
Tacke, F. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1442436 · Cited by 130
Ratziu, V., Sanyal, A. J., Loomba, R. S., Rinella, M. E., Harrison, S. A., Anstee, Q. M., Goodman, Z. D., Bédossa, P., MacConell, L., Shringarpure, R., et al. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.06.017 · Cited by 130
Pais, R., Fartoux, L., Goumard, C., Scatton, O., Wendum, D., Rosmorduc, O., & Ratziu, V. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14261 · Cited by 129
Hepatocellular carcinoma in non‐alcoholic steatohepatitis: Growing evidence of an epidemic?
Hashimoto, E., & Tokushige, K. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00872.x · Cited by 128
Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis
Du, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i2.569 · Cited by 128
Ampuero, J., Aller, R., Gallego‐Durán, R., Bañales, J. M., Crespo, J., García‐Monzón, C., Pareja, M. J., Gómez, E. V., Caballería, J., Escudero‐García, D., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15015 · Cited by 127
Zhou, Y.-Y., Zhou, X.-D., Wu, S.-J., Hu, X.-Q., Tang, B., Poucke, S. V., Pan, X.-Y., Wu, W.-J., Gu, X.-M., Fu, S.-W., et al. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001075 · Cited by 125 · cited 1×
“Importantly, MAFLD is associated with an increased risk of fatal and/or non-fatal cardiovascular events and the risk is higher among patients with more severe liver disease [102, 103].”
BackgroundSelf-citationToward More Accurate Nomenclature for Fatty Liver Diseases
Eslam, M., Sanyal, A. J., & George, J. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.064 · Cited by 125
Self-citationSubichin, M., Clanton, J., Makuszewski, M., Bohon, A., Zografakis, J. G., & Dan, A. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.06.015 · Cited by 124
Zhang, Y., Shi, J., Peng, Y. H., Zhao, Z., Zheng, Q., Wang, Z., Liu, K., Jiao, S., Qiu, K., Zhou, Z., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001596 · Cited by 124
Mazzotti, A., Caletti, M. T., Brodosi, L., Domizio, S. D., Forchielli, M. L., Petta, S., Bugianesi, E., Bianchi, G. P., & Marchesini, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.07.013 · Cited by 123
Obesity and Non-Alcoholic Fatty Liver Disease in Chronic Hepatitis C
Younossi, Z. M., McCullough, A. J., Ong, J. P., Barnes, D. S., Post, A. B., Tavill, A. S., Bringman, D., Martin, L. M., Assmann, J., Gramlich, T. L., et al. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000135372.10846.2a · Cited by 120
Harimoto, N., Yoshizumi, T., Shimokawa, M., Sakata, K., Kimura, K., Itoh, S., Ikegami, T., Ikeda, T., Shirabe, K., & Maehara, Y. (2016) · Hepatology Research · doi:10.1111/hepr.12674 · Cited by 120
Health‐related quality of life in patients with non‐alcoholic fatty liver disease
Dan, A., Kallman, J. B., Wheeler, A. G., Younoszai, Z., Collantes, R. S., Bondini, S., Gerber, L. H., & Younossi, Z. M. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03426.x · Cited by 117
From NAFLD to MAFLD: a “redefining” moment for fatty liver disease
Zheng, K. I., Fan, J., Shi, J., Wong, V. W., Eslam, M., George, J., & Zheng, M. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000981 · Cited by 117
Self-citationGallstone disease in non‐alcoholic fatty liver: Prevalence and associated factors
Loria, P., Lonardo, A., Lombardini, S., Carulli, L., Verrone, A. M., Ganazzi, D., Rudilosso, A., D’Amico, R., Bertolotti, M., & Carulli, N. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03924.x · Cited by 115
Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis
Sinn, D. H., Cho, S. J., Gu, S., Seong, D., Kang, D., Kim, H., Yi, B.-K., Paik, S. W., Güallar, E., Cho, J., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.001 · Cited by 115
Chan, W., Treeprasertsuk, S., Goh, G. B., Fan, J., Song, M. J., Charatcharoenwitthaya, P., Duseja, A. K., Dan, Y.-Y., Imajo, K., Nakajima, A., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.03.006 · Cited by 115
Self-citationPrevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units
Hu, X., Huang, Y., Bao, Z., Wang, Y., Shi, D., Liu, F., Gao, Z., & Yu, X. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-123 · Cited by 114
Younossi, Z. M., Stepanova, M., Henry, L. L., Racila, A., Lam, B. P., Phạm, T. T. H., & Hunt, S. (2017) · Liver International · doi:10.1111/liv.13391 · Cited by 113
Coronary artery disease in decompensated patients undergoing liver transplantation evaluation
Patel, S. S., Nabi, E. H., Guzmán, L., Abbate, A., Bhati, C. S., Stravitz, R. T., Reichman, T., Matherly, S. C., Driscoll, C. J., Lee, H., et al. (2018) · Liver Transplantation · doi:10.1002/lt.25012 · Cited by 112
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosis
Bengtsson, B., Stal, P. I., Wåhlin, S., Björkström, N. K., & Hagström, H. (2019) · Liver International · doi:10.1111/liv.14087 · Cited by 112
O’Leary, J. G., Landaverde, C. E., Jennings, L. W., Goldstein, R. M., & Davis, G. L. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.04.007 · Cited by 110
Huber, Y., Boyle, M., Hallsworth, K., TINIAKOS, D. G., Straub, B. K., Labenz, C., Ruckes, C., Galle, P. R., Romero‐Gómez, M., Anstee, Q. M., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.12.016 · Cited by 110
Jin, Y., Kim, K. M., Hwang, S., Lee, S. G., Ha, T., Song, G., Jung, D., Kim, K., Yu, E., Shim, J. H., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07165.x · Cited by 108
Incidence of and Risk Assessment for Adverse Cardiovascular Outcomes After Liver Transplantation
Konerman, M. A., Fritze, D. M., Weinberg, R. L., Sonnenday, C. J., & Sharma, P. (2017) · Transplantation · doi:10.1097/tp.0000000000001710 · Cited by 108
Amanullah, I., Khan, Y. H., Anwar, I., Gulzar, A., Mallhi, T. H., & Aftab, R. A. (2019) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2018-136364 · Cited by 104
Nascimbeni, F., Bédossa, P., Fedchuk, L., Pais, R., Charlotte, F., Lebray, P., Poynard, T., & Ratziu, V. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.12.008 · Cited by 101
Aguilar-Olivos, N. E., Almeda-Valdes, P., Aguilar-Salinas, C. A., Uribe, M., & Méndez-Sánchez, N. (2016) · Metabolism · doi:10.1016/j.metabol.2015.09.004 · Cited by 100
The impact of obesity and metabolic syndrome on alcoholic liver disease
Chiang, D. J., & McCullough, A. J. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.006 · Cited by 99
The NAFLD‐MAFLD debate: Eminence vs evidence
Fouad, Y. M., Elwakil, R., Elsahhar, M., Said, E., Bazeed, S. E. S., Gomaa, A., Hashim, A. H., Kamal, E., Mehrez, M. I., & Attia, D. I. (2020) · Liver International · doi:10.1111/liv.14739 · Cited by 99
Prevalence and risk factors of non‐alcoholic fatty liver disease in Bangladesh
Alam, S., Fahim, S. M., Chowdhury, M. A. B., Hassan, M. Z., Azam, G., Mustafa, G., Ahsan, M., & Ahmad, N. (2018) · JGH Open · doi:10.1002/jgh3.12044 · Cited by 96
Self-citationCharatcharoenwitthaya, P., Pongpaibul, A., Kaosombatwattana, U., Bhanthumkomol, P., Bandidniyamanon, W., Pausawasdi, N., & Tanwandee, T. (2016) · Liver International · doi:10.1111/liv.13271 · Cited by 95
Self-citationRegional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea
Jeong, E. H., Jun, D. W., Cho, Y. K., Choe, Y. G., Ryu, S., Lee, S. M., & Jang, E. C. (2013) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2013.19.3.266 · Cited by 94
Chan, W., Tan, A. T. B., Vethakkan, S. R., Tah, P., Vijayananthan, A., & Goh, K. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12204 · Cited by 94
Self-citationPeleg, N., Issachar, A., Arbib, O. S., Cohen‐Naftaly, M., Braun, M., Leshno, M., Barsheshet, A., & Shlomai, A. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.02.002 · Cited by 93
The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease
Bayoumi, A., Grønbæk, H., George, J., & Eslam, M. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.03.003 · Cited by 92
Self-citationChong, C. W., Ahmad, A. F., Lim, Y. A. L., Teh, C. S. J., Yap, I. K. S., Lee, S. C., Chin, Y. T., Loke, P., & Chua, K. H. (2015) · Scientific Reports · doi:10.1038/srep13338 · Cited by 91
Gómez, E. V., Bertot, L. C., Wong, V. W., Castellanos, M., la Fuente, R. A., Eslam, M., Wong, G. L., George, J., Romero‐Gómez, M., & Adams, L. A. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.083 · Cited by 90
Self-citationNishikawa, H., Nishijima, N., Enomoto, H., Sakamoto, A., Nasu, A., Komekado, H., Nishimura, T., Kita, R., Kimura, T., Iijima, H., et al. (2017) · Oncology Letters · doi:10.3892/ol.2017.6287 · Cited by 89
Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis
Zou, T., Zhang, C., Zhou, Y.-F., Han, Y., Xiong, J.-J., Wu, X., Chen, Y., & Zheng, M. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001135 · Cited by 88
Self-citationYounossi, Z. M., Stepanova, M., Anstee, Q. M., Lawitz, E., Wong, V. W., Romero‐Gómez, M., Kersey, K., Li, G., Subramanian, G. M., Myers, R. P., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.02.024 · Cited by 87
Self-citationPrevalence and risk factors of fatty liver disease in Chengdu, Southwest China.
Li, H., Wang, Y., Tan, K., Zeng, L., Liu, L., Liu, F., Zhou, T., Chen, E., & Tang, H. W. (2009) · PubMed · Cited by 86
Kudo, M., Ueshima, K., Osaki, Y., Hirooka, M., Imai, Y., Aso, K., Numata, K., Kitano, M., Kumada, T., Izumi, N., et al. (2019) · Liver Cancer · doi:10.1159/000501082 · Cited by 85
Stockman, J. A. (2012) · Yearbook of Pediatrics · doi:10.1016/j.yped.2011.06.073 · Cited by 84
Keskin, M., Hayıroğlu, M. İ., Uzun, A. O., Güvenç, T. S., Şahin, S., & Kozan, Ö. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.107 · Cited by 83
Goh, S.-C., Ho, E. L. M., & Goh, K. (2012) · Hepatology International · doi:10.1007/s12072-012-9359-2 · Cited by 82
Jung, K., Kim, M., So, J., Lee, S., Ko, S., & Shin, D. (2020) · Hepatology · doi:10.1002/hep.31679 · Cited by 82
Lee, H. W., Wong, G. L., Kwok, R., Choi, K. C., Chan, C. K., Shu, S. S., Leung, J. K., Chim, A. M., Luk, A. O. Y., Ronald, C. W., et al. (2020) · Hepatology · doi:10.1002/hep.31142 · Cited by 81
Self-citationγδ T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming
Torres‐Hernandez, A., Wang, W., Nikiforov, Y., Tejada, K., Torres, L., Kalabin, A., Adam, S., Wu, J., Lu, L., Chen, R., et al. (2020) · Hepatology · doi:10.1002/hep.30952 · Cited by 80
Khattab, M. A., Eslam, M., Sharwae, M. A., Shatat, M., Ali, A., & Hamdy, L. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.110 · Cited by 79
Self-citationCho, E. J., Kwack, M. S., Jang, E. S., You, S. J., Lee, J., Kim, Y. J., Yoon, J., & Lee, H.-S. (2011) · Digestion · doi:10.1159/000333210 · Cited by 77
Occult hepatitis B virus and hepatocellular carcinoma
Pollicino, T., & Saitta, C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i20.5951 · Cited by 77
Noureddin, M., Wong, M. M., Todo, T., Lu, S. C.-L., Sanyal, A. J., & Mena, E. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i11.1269 · Cited by 77
Insulin resistance and hepatitis C: an evolving story
Eslam, M., Khattab, M. A., & Harrison, S. A. (2011) · Gut · doi:10.1136/gut.2010.228262 · Cited by 75
Self-citationTada, T., Kumada, T., Toyoda, H., Sone, Y., Takeshima, K., Ogawa, S., Goto, T., Wakahata, A., Nakashima, M., Nakamuta, M., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14554 · Cited by 75
Kaya, E., Bakır, A., Kani, H. T., Demirtaş, C. Ö., Keklikkıran, Ç., & Yilmaz, Y. N. (2019) · Gut and Liver · doi:10.5009/gnl19173 · Cited by 75
Self-citationDudekula, A. B., Rachakonda, V. P., Shaik, B., & Behari, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111808 · Cited by 73
Rastogi, A., Shasthry, S. M., Agarwal, A., Bihari, C., Jain, P., Jindal, A., & Sarin, S. K. (2017) · Apmis · doi:10.1111/apm.12742 · Cited by 73
Self-citationNon-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health
Eslam, M., Fan, J., & Méndez‐Sánchez, N. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30090-x · Cited by 73
Self-citationDong, Y., Lv, Q., Li, S., Wu, Y., Li, L., Li, J., Zhang, F., Sun, X., & Tong, N. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.11.009 · Cited by 71
VanWagner, L. B., Lapin, B. R., Skaro, A. I., Lloyd‐Jones, D. M., & Rinella, M. E. (2015) · Liver International · doi:10.1111/liv.12872 · Cited by 67
Younossi, Z. M. (2018) · Hepatology · doi:10.1002/hep.30125 · Cited by 67
Tang, W., Xu, Q., Hong, T., Tong, G., Feng, W., Shen, S., Bi, Y., & Zhu, D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2713 · Cited by 65
Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma
Takada, H., Kurosaki, M., Nakanishi, H., Takahashi, Y., Itakura, J., Tsuchiya, K., Yasui, Y., Tamaki, N., Takaura, K., Komiyama, Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198812 · Cited by 65
Phase 3 drug pipelines in the treatment of non‐alcoholic steatohepatitis
Sumida, Y., Okanoue, T., Nakajima, A., & Japan Study Group of NAFLD (JSG‐NAFLD) (2019) · Hepatology Research · doi:10.1111/hepr.13425 · Cited by 65
Hamurcu, P., Kaya, E., Alphan, E., & Yilmaz, Y. N. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001656 · Cited by 65
Self-citationPrevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China
Li, H., Guo, M., An, Z., Meng, J., Jiang, J., Song, J., & Wu, W. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17061818 · Cited by 65
Zhou, J., Ke, Y., Lei, X., Wu, T., Li, Y., Bao, T., Tang, H., Zhang, C., Wu, X., Wang, G., et al. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.11.008 · Cited by 64
Alkayyali, T., Qutranji, L., Kaya, E., Bakır, A., & Yilmaz, Y. N. (2020) · Acta Diabetologica · doi:10.1007/s00592-019-01467-7 · Cited by 63
Self-citationTokushige, K., Hyogo, H., Nakajima, T., Ono, M., Kawaguchi, T., Honda, K., Eguchi, Y., Nozaki, Y., Kawanaka, M., Tanaka, S., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1129-1 · Cited by 61
Self-citationImai, K., Takai, K., Watanabe, S., Hanai, T., Suetsugu, A., Shiraki, M., & Shimizu, M. (2017) · Nutrients · doi:10.3390/nu9101054 · Cited by 61
Melere, M., Targa-Ferreira, C., Lessa-Horta, B., Epifânio, M., Mouzaki, M., & de Mattos, Â. A. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0011.7380 · Cited by 60
The Impact of Coronary Artery Disease and Statins on Survival After Liver Transplantation
Patel, S. S., Rodríguez, V., Siddiqui, M. B., Faridnia, M., Lin, F., Chandrakumaran, A., Laurenzano, J., Clinton, J. W., Kowlgi, G. N., Kirkman, D. L., et al. (2019) · Liver Transplantation · doi:10.1002/lt.25613 · Cited by 60
Ha, Y., Kim, D. J., Han, S., Chon, Y. E., Lee, Y. B., Kim, M. N., Lee, J. H., Park, H., Rim, K. S., & Hwang, S. G. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2017.232 · Cited by 59
Association between metabolic abnormalities and hepatitis C-related hepatocellular carcinoma
Khattab, M. A., Eslam, M., Mousa, Y. I., Ela-adawy, N., Fathy, S., Shatat, M., Abd-Aalhalim, H., Kamal, A., & Sharawe, M. A. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31462-0 · Cited by 56
Self-citationBril, F., Barb, D., Lomonaco, R., Lai, J., & Cusi, K. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.018 · Cited by 55 · cited 1×
“In some clinical trials, a > 30% relative reduction in liver fat fraction correlated with histological improvements in the activity score or resolution of steatohepatitis [118], though the same has not been reported in other studies [119], and the association is probably drug-specific.”
ResultTolman, K. G., Freston, J. W., Kupfer, S., & Pérez, A. (2009) · Drug Safety · doi:10.2165/11316510-000000000-00000 · Cited by 55
Doycheva, I., Patel, N. S., Peterson, M. R., & Loomba, R. S. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.10.008 · Cited by 55
Nayak, N. C., Vasdev, N., Saigal, S., & Soin, A. S. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.06.021 · Cited by 53
Liver transplantation in India
Narasimhan, G., Kota, V., & Rela, M. (2016) · Liver Transplantation · doi:10.1002/lt.24459 · Cited by 53
Mahady, S. E., Macaskill, P., Craig, J. C., Wong, G. L., Chu, C. W., Chan, H. L., George, J., & Wong, V. W. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.02.031 · Cited by 53
Self-citationBertot, L. C., Jeffrey, G. P., Jacques, B., McCaughan, G. W., Crawford, M., Angus, P., Jones, R. M., Gane, E. J., MUNN, S. R., Macdonald, G. A., et al. (2019) · Liver Transplantation · doi:10.1002/lt.25361 · Cited by 53
Self-citationEthnicity and the diagnosis gap in liver disease: a population-based study
Alazawi, W., Mathur, R., Abeysekera, K. W. M., Hull, S., Boomla, K., Robson, J. P., & Foster, G. R. (2014) · British Journal of General Practice · doi:10.3399/bjgp14x682273 · Cited by 50
Seki, Y., Kakizaki, S., Horiguchi, N., Hashizume, H., Tojima, H., Yamazaki, Y., Sato, K., Kusano, M., Yamada, M., & Kasama, K. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1114-8 · Cited by 50
Kuk, J. L., Church, T. S., Blair, S. N., & Ross, R. (2009) · Obesity · doi:10.1038/oby.2009.414 · Cited by 48
Alam, S., Hasan, M. J., Khan, M. A. S., Alam, M., & Hasan, N. (2019) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2019-0023 · Cited by 48
Self-citationImpact of cancer rehabilitation on the prognosis of patients with hepatocellular carcinoma
Hashida, R., Kawaguchi, T., Koya, S., Hirota, K., Goshima, N., Yoshiyama, T., Otsuka, T., Bekki, M., Iwanaga, S., Nakano, D., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.11345 · Cited by 48
Self-citationKaya, E., Bakır, A., Eren, F., & Yilmaz, Y. N. (2020) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2020.0006 · Cited by 48
Self-citationSalomone, F., Sharaiha, R. Z., & Boškoski, I. (2020) · Liver International · doi:10.1111/liv.14441 · Cited by 48
Are, V. S., Vuppalanchi, R., Gómez, E. V., & Chalasani, N. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.06.070 · Cited by 48
Eslam, M., Ampuero, J., Jover‐Cobos, M., Abd-Elhalim, H., Rincón, D., Shatat, M., Camacho, I., Kamal, A., Iacono, O. L., Nasr, Z., et al. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31343-2 · Cited by 47
Self-citationPortillo-Sánchez, P., Bril, F., Lomonaco, R., Barb, D., Orsak, B., Bruder, J., & Cusi, K. J. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12833 · Cited by 47
Obeticholic acid for the treatment of nonalcoholic steatohepatitis
Shah, R. A., & Kowdley, K. V. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1748498 · Cited by 47
Park, J. H., Park, M., Lee, S. J., Jeong, W. K., Lee, J. Y., Park, M. J., Lee, S. S., Han, K., Nam, C. M., Park, S. H., et al. (2019) · Radiology · doi:10.1148/radiol.2019190183 · Cited by 46
Mardian, Y., Yano, Y., Ratnasari, N., Choridah, L., Wasityastuti, W., Setyawan, N. H., & Hayashi, Y. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1152-4 · Cited by 45
Jafarov, F., Kaya, E., Bakır, A., Eren, F., & Yilmaz, Y. N. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001573 · Cited by 43
Self-citationObeticholic acid: towards first approval for NASH
Eslam, M., Alvani, R., & Shiha, G. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32963-0 · Cited by 43
Self-citationKawaguchi, T., Tokushige, K., Hyogo, H., Aikata, H., Nakajima, T., Ono, M., Kawanaka, M., Sawada, K., Imajo, K., Honda, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28650-0 · Cited by 42
Self-citationZheng, K. I., Liu, W., Pan, X.-Y., Ma, H., Zhu, P., Wu, X., Targher, G., Byrne, C. D., Wang, X., Chen, Y., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001174 · Cited by 41
Self-citationSarkhy, A. A. A., Al‐Hussaini, A. A., & Nobili, V. (2014) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.132983 · Cited by 38
New abdominal collaterals at ultrasound: A clue of progression of portal hypertension
Berzigotti, A., Merkel, C., Magalotti, D., et al. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.08.011 · Cited by 38
Tabibian, J. H., Lazo, M., Durazo, F. A., Yeh, H. C., Tong, M. J., & Clark, J. M. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06443.x · Cited by 36
Mehtälä, J., Khanfir, H., Bennett, D., Ye, Y., Korhonen, P. A., & Hoti, F. J. (2018) · Diabetology International · doi:10.1007/s13340-018-0360-4 · Cited by 36
Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease
Fu, C., Wai, J. W., Mustapha, N. R. N., Irlès, M., Wong, G. L., Mahadeva, S., Shili, S., Chan, A. W. H., Merrouche, W., Chan, H. L.-Y., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.09.027 · Cited by 36
Self-citationCryptogenic cirrhosis in the region where obesity is not prevalent
Kojima, H. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i13.2080 · Cited by 32
Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
Khoo, S., Wong, V. W., Goh, G. B., Fan, J., Chan, W., Seto, W., & Chow, W. C. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14794 · Cited by 31
Self-citationEvolution of Acyl-Substrate Recognition by a Family of Acyl-Homoserine Lactone Synthases
Christensen, Q. H., Brecht, R. M., Dudekula, D., Greenberg, E. P., & Nagarajan, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112464 · Cited by 29
The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis
Clanton, J., & Subichin, M. P. (2016) · Surgical Clinics of North America · doi:10.1016/j.suc.2016.03.008 · Cited by 27
Chan, W., Bahar, N., Razlan, H., et al. (2014) · Hepatology International · doi:10.1007/s12072-013-9510-8 · Cited by 26
Self-citationSarcopenia and nonalcoholic fatty liver disease: a causal relationship
Pacifico, L., Perla, F. M., & Chiesa, C. (2019) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2018.11.11 · Cited by 24
Zheng, K. I., Liu, C., Li, J. V., Zhao, L., Zheng, M., Wang, F., & Qi, X. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.06.042 · Cited by 23
Self-citationGut Microbiota of Children Living in Rural South Thailand and Urban Singapore
Mah, K. W., Sangsupawanich, P., Tunyapanit, W., Bever, H. V., Shek, L. P., Chua, K. Y., & Lee, B. W. (2008) · Allergology International · doi:10.2332/allergolint.o-07-501 · Cited by 22
Tung, T., Chang, T.-H., Chiu, W., Lin, T.-H., Shih, H., Chang, M.-H., & Liu, J. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-315 · Cited by 22
Salomone, F., Petta, S., Micek, A., Pipitone, R. M., Distefano, A., Castracani, C. C., Rini, F., Rosa, M. D., Gardi, C., Calvaruso, V., et al. (2020) · Liver International · doi:10.1111/liv.14608 · Cited by 22
Lee, J., Kim, Y., Kim, H. Y., Sinniah, M., Chong, C., & Song, H. (2015) · Scientific Reports · doi:10.1038/srep18077 · Cited by 20
Chow, W. C., Tai, E. S., Lian, S., Tan, C., Sng, I., & Ng, H. S. (2007) · PubMed · Cited by 20
Tang, D., Yuan, F., Ma, X., Qu, H., Li, Y., Zhang, W., Ma, H., Liu, H., Yang, Y., Xu, L., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15359 · Cited by 19
Shiha, G. E.-S., El-Etreby, S., Bahgat, M. M., Hamed, M., Sherbini, M. E., Ghoneem, E. A., Zalata, K. R., Soliman, R., El-Basiouny, M., & Mikhail, N. N. H. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.3138 · Cited by 18
Self-citationBilleter, A. T., Müller, P. C., Albrecht, T., Roessler, S. K., Löffler, M., Murtha-Lemekhova, A., Mehrabi, A., Müller-Stich, B. P., & Hoffmann, K. (2020) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-020-04628-0 · Cited by 18
Vongsuvanh, R., van der Poorten, D., & George, J. (2013) · Hepatology International · doi:10.1007/s12072-013-9453-0 · Cited by 13
Self-citationGenetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer
Penney, K. L., Banbury, B. L., Bien, S. A., Harrison, T. A., Hua, X., Phipps, A. I., Sun, W., Song, M., Joshi, A. D., Alberts, S. R., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.11.046 · Cited by 13
Prevalence and related factors of non-alcoholic fatty liver disease among the elderly in Taiwan
Hung, S.-C., Lai, S.-W., Chen, M.-C., Li, P.-C., & Lin, K. (2012) · European Geriatric Medicine · doi:10.1016/j.eurger.2012.11.004 · Cited by 11
Eslam, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i41.7055 · Cited by 10
Self-citationA Changing Etiologic Scenario in Liver Transplantation: A Single-Center Cohort Study From Turkey
Serin, A., Şahin, T., Arikan, B. T., Emek, E., Bozkurt, B., & Tokat, Y. (2019) · Transplantation Proceedings · doi:10.1016/j.transproceed.2019.01.190 · Cited by 8
Cited by
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000520 · Cited by 3,476
Self-citationA multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.06.003 · Cited by 3,100
Self-citationGlobal epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Huang, D. Q., El-Serag, H. B., & Loomba, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00381-6 · Cited by 1,855
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2023.101133 · Cited by 844
Self-citation
Metadata
- Authors
- Eslam, M., Sarin, S. K., Wong, V. W.-S., Fan, J.-G., Kawaguchi, T., Ahn, S. H., Zheng, M.-H., Shiha, G., Yilmaz, Y., Gani, R., Alam, S., Dan, Y. Y., Kao, J.-H., Hamid, S., Cua, I. H., Chan, W.-K., Payawal, D., Tan, S.-S., Tanwandee, T., Adams, L. A., Kumar, M., Omata, M., & George, J.
- Venue
- Hepatology International
- Published
- 2020-10-01
- Volume
- 14
- Issue
- 6
- Pages
- 889-919
- ISSN
- 1936-0533 (ISSN-L)
- 1936-0541
- OpenAlex
- W3091471007
- Cited by
- 833
- References
- 327
- FWCI
- 67.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.